Clinical Trials
8 trialsNCT05367765 2022-05-10
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4 Not yet recruiting
NCT05353205 2022-04-29
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT04677439 2022-03-16
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
Shenzhen Second People's Hospital
Phase 4 Unknown
NCT04925141 2021-06-14
A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4 Completed
NCT01131325 2021-05-20
MACS1148
Novartis
Phase 4 Terminated
NCT00003398 2019-10-17
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 4 Completed
NCT03332511 2017-11-06
ENESTKorea
Seoul National University Hospital
Phase 4 Completed
NCT01660906 2016-11-22
Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
Bristol-Myers Squibb
Phase 4 Completed